#PLK1
Onvansertib is a PLK1 inhibitor, and the interest in RAS-mutated colorectal cancer comes from synthetic lethality, since RAS-mutant cells lean heavily on PLK1 during mitosis. A nice example of targeting a dependency rather than the mutation itself.
November 16, 2026 at 9:02 PM
Cardiff Oncology's PLK1 inhibitor onvansertib has won FDA Orphan Drug designation for chronic myelomonocytic leukaemia. Phase 1 data showed preliminary efficacy in roughly 40% of CMML patients.
Cardiff Oncology wins FDA Orphan Drug tag for onvansertib in CMML
The San Diego biotech's PLK1 inhibitor gains rare-disease benefits as Phase 1 data show preliminary efficacy in roughly 40% of myeloproliferative CMML patients.
thebiotechtimes.com
November 12, 2026 at 8:00 PM
⭐ New Editor's Choice Article!

📖 Can the novel N-degron-based #PROTAC NC1 overcome #chemoresistance in cervical #cancer by #targeting PLK1 for degradation and suppressing #tumor growth?

🔗 www.mdpi.com/1999-4923/17...

#Pharmaceutics #CervicalCancer #PLK1 #PROTAC #EditorsChoice
October 29, 2026 at 10:01 AM
Francis Barr and coworkers describe a new principle for phosphatase substrate recognition, where disordered regions of phosphatase regulatory subunits mimic kinase-activating subunits, & are themselves differentially regulated by PLK1
@tomogolgier.bsky.social et al
link.springer.com/article/10.1...
Activator mimicry by PP6 regulatory subunits directs Aurora A dephosphorylation in mitosis - The EMBO Journal
Aurora A kinase is a conserved regulator of mitotic spindle assembly whose activity must be precisely balanced to ensure genome stability. Its activation at centrosomes and spindle microtubules is pro...
link.springer.com
October 27, 2026 at 12:48 PM
The authors included RRIDs in their in Science Advances paper! Thanks for making your methods matter! #ReproducibleResearch #STMpublishing #BetterScience
GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination
Read the full paper: GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination
doi.org
October 9, 2026 at 7:04 AM
RRIDs were included in this in Theranostics paper. RRIDs improve reproducibility in scientific research. #OpenScience #OpenResearch #BetterScience
PLK1 stabilizes β-catenin to drive colorectal carcinogenesis through NFKB2-mediated transcriptional activation of USP2a and site-specific phosphorylation
Read the full paper: PLK1 stabilizes β-catenin to drive colorectal carcinogenesis through NFKB2-mediated transcriptional activation of USP2a and site-specific phosphorylation
doi.org
October 9, 2026 at 7:05 AM
Bora, CEP192, and Cenexin selectively regulate Plk1 processes: Bora aids mitotic entry; CEP192 in centrosome maturation; Cenexin in centriole disengagement. Science! PMID:42380115, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-75033-5 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Bora, CEP192 and Cenexin regulate distinct Plk1-dependent cell and centrosome cycle transitions | Nature Communications
Polo-like kinase 1 (Plk1) regulates multiple steps of the cell and centrosome cycle, including mitotic entry, DNA-damage recovery, centrosome maturation and centriole disengagement. Plk1 activity depends on several independent cofactors, such as the cytoplasmic Bora, and the centrosomal proteins Cep192 and Cenexin. However, whether these Plk1 coactivators differentially regulate the Plk1-dependent processes is unknown. Here, we show that each Plk1 coactivator controls different cell and centrosome cycle transitions in human cells. We find that Plk1 already acts in S-phase, where under the control of Cep192 and Aurora A it promotes replication origin firing. Bora is the main Plk1 activator driving mitotic entry, DNA-damage recovery and centrosome maturation in G2, while centriole disengagement is mainly regulated by Cep192 and Cenexin. Our results thus uncover a complex Plk1 activation regulatory network, in which distinct upstream activators dictate its activity in a context-dependent
doi.org
October 3, 2026 at 5:00 PM
📢 Publication Alert! 📢
Excited to share that our latest work is now out in @natcomms.nature.com ! We uncovered a new role of Plk1 in regulating DNA replication.
Congratulations on this fantastic achievement and great work by @devdwdi.bsky.social and team! 🎉
October 2, 2026 at 8:13 AM
PXD080479 🚨

Detection of the mitotic interactionome of the human PLK1 protein kinase.

🚨 New dataset alert! 🚨
September 29, 2026 at 3:00 PM
RRID:AB_2878120 from @proteintech.bsky.social was used by authors in their American Journal of Physiology-Lung Cellular and Molecular Physiology paper. Thanks for making your methods matter! #OpenResearch #reproducibility #accelerateopenscience
PLK1 inhibition by volasertib suppresses key transcriptional regulators underlying fibroblast activation and pulmonary fibrosis
Read the full paper: PLK1 inhibition by volasertib suppresses key transcriptional regulators underlying fibroblast activation and pulmonary fibrosis
doi.org
September 9, 2026 at 7:02 AM
Authors used HS-DN-Plk1 from @addgene.bsky.social in their study. Including #RRIDs will make this less ambiguous.

SciScore made a table with this resource, see “Automated Services” module (download as csv, xml or #jats) #RRID #OpenScience
Intracellular carbon storage enables starvation survival in marine bacteria
www.biorxiv.org
September 4, 2026 at 12:00 PM
@thermofishersci.bsky.social's resource, RRID:AB_1518748, was just reported to be used in the paper. Thanks for making your methods matter! #methodsmatter #ReproducibleResearch #RRID
Cell-state–dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells
Read the full paper: Cell-state–dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells
doi.org
September 4, 2026 at 7:01 AM
Cell-state-dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells https://www.biorxiv.org/content/10.64898/2026.08.25.746864v1
August 26, 2026 at 8:46 AM
Cell-state-dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells https://www.biorxiv.org/content/10.64898/2026.08.25.746864v1
August 26, 2026 at 8:46 AM
New insights reveal that Chk2 keeps PLK1 active during cell division, preventing errors in chromosome alignment and segregation. Without Chk2, cells struggle with division and become more vulnerable to PLK1 inhibitors. This suggests Chk2 could help predict treatment responses in some therapies.
Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation.
Published in Nature communications
doi.org
January 1, 2025 at 2:00 PM
High levels of PLK1 in cancer cells can make them more vulnerable to certain treatments. The study found that PLK1 overexpression impairs DNA repair, making these cells more sensitive to PARP inhibitors. This insight could pave the way for new cancer therapies targeting PLK1.
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition.
Published in Scientific reports
doi.org
December 29, 2024 at 8:00 PM
one black crow said, mockingly,
"perhaps you won't be yourself by the end, but oh well"

www.youtube.com/watch?v=PLK1...
"ネヴァモア" sasalasa (sasakure.‌UK × lasah) / nevermore
YouTube video by sasakure. UK
www.youtube.com
February 20, 2026 at 4:48 AM
Japanese encephalitis virus NS1 and NS1’ proteins induce vimentin rearrangement via the CDK1-PLK1 axis to promote viral replication
journals.asm.org/doi/10.1128/...
Japanese encephalitis virus NS1 and NS1’ proteins induce vimentin rearrangement via the CDK1-PLK1 axis to promote viral replication | Journal of Virology
Japanese encephalitis virus (JEV) is a mosquito-borne orthoflavivirus that causes severe encephalitis in humans, particularly in Asia. Despite the availability of a safe and effective vaccine, JEV inf...
journals.asm.org
April 24, 2024 at 11:17 PM
Starting signal for cell division: Molecular switch ensures that cells divide at the right time
About 100 cells divide every second in our body. A key protein in cell division is a protein kinase termed Plk1, because it activates other proteins ...
weiterlesen
April 1, 2025 at 9:13 AM
Startschuss für die Zellteilung: Molekularer Schalter sorgt dafür, dass Zellen sich rechtzeitig teilen
Rund 100 Zellen teilen sich jede Sekunde in unserem Körper. Ein Schlüsselprotein in der Zellteilung ist Polo-like Kinase 1, kurz Plk1, den...
weiterlesen
April 1, 2025 at 9:13 AM
How cells maintain their central processing unit for cell division
MPI scientists from Dortmund unveiled the role of enzyme PLK1 in regulating centromeres’ restoration after cell division, a process at the basis of life...
weiterlesen
October 7, 2024 at 7:24 AM
Wie Zellen ihre zentrale Verarbeitungseinheit für die Zellteilung aufrechterhalten
Dortmunder Max-Planck-Forschende haben die Rolle des Enzyms PLK1 bei der Regulierung der Wiederherstellung von Zentromeren nach der Zellteilung aufgedeckt...
weiterlesen
October 7, 2024 at 7:22 AM